Loading…

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

Saved in:
Bibliographic Details
Published in:Dermatology and therapy 2024, Vol.14 (1), p.183-185
Main Authors: Rand, Kim, Ramos-Goñi, Juan Manuel, Akmaz, Bülent, Solé-Feu, Laia, Armario-Hita, José-Carlos
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2193-8210
2190-9172
DOI:10.1007/s13555-023-01076-x